loader
Please Wait
Applying Filters...

Approved Drug Products containing (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one listed in the FDA Orange Book. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BRISTOL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

World Dairy Expo 2024
Not Confirmed
arrow
arrow
World Dairy Expo 2024
Not Confirmed

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Approval Date : 2023-11-15

Application Number : 218213

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

World Dairy Expo 2024
Not Confirmed
arrow
arrow
World Dairy Expo 2024
Not Confirmed

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 160MG

Approval Date : 2024-06-11

Application Number : 218213

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank